Quadrant Biosciences Inc

CIK: 1651239DEIncorporated: 2015-03-13

Current Offering

$50,000
Target Amount
$1,070,000
Maximum Amount
2021-02-21
Deadline

Security Details

Type: Convertible Note
Price per share: $1.00
Shares offered: 50,000+

Offering Costs

Cash commission: 3%
3% of the offering amount upon a successful fundraise.
Equity compensation: 0%
No

Financial Reports

Offering via Wefunder

Offering History

As of 2020-08-25
Raising $50,000 -$1,070,000 via 50,000+ shares of convertible Note at $1.00 per share
Deadline: 2021-02-21
Filing date2020-08-25
Current employees42
Act received most recent fiscal year$12,653
Act received prior fiscal year$24,077
Cash equi most recent fiscal year$1,289,474
Cash equi prior fiscal year$4,945,726
Cost goods sold most recent fiscal year$426,512
Cost goods sold prior fiscal year$192,281
Long term debt most recent fiscal year$5,349,064
Long term debt prior fiscal year$5,398,139
Net income most recent fiscal year-$7,296,264.00
Net income prior fiscal year-$6,943,093.00
Revenue most recent fiscal year$413,811
Revenue prior fiscal year$115,778
Short term debt most recent fiscal year$736,722
Short term debt prior fiscal year$650,959
Tax paid most recent fiscal year-$204,267.00
Tax paid prior fiscal year-$237,516.00
Total asset most recent fiscal year$8,672,233
Total asset prior fiscal year$9,091,991

Company Information

Corporation
DE
2015-03-13

Latest Metrics

Employees42
Total Assets$8,672,233
Cash on Hand$1,289,474
Revenues$413,811
Net Income-$7,296,264.00

Crowdfunding Portals

This company is raising funds through this portal